BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Laar M, van Amsterdam WAC, van Lindert ASR, de Jong PA, Verhoeff JJC. Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis. Radiother Oncol 2020;151:152-75. [PMID: 32710990 DOI: 10.1016/j.radonc.2020.07.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Manafi-Farid R, Askari E, Shiri I, Pirich C, Asadi M, Khateri M, Zaidi H, Beheshti M. [18F]FDG-PET/CT radiomics and artificial intelligence in lung cancer: Technical aspects and potential clinical applications. Semin Nucl Med 2022:S0001-2998(22)00035-6. [PMID: 35717201 DOI: 10.1053/j.semnuclmed.2022.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Messina G, Tartaglia N, Ambrosi A, Porro C, Campanozzi A, Valenzano A, Corso G, Fiorelli A, Polito R, Santini M, Monda M, Tafuri D, Messina G, Messina A, Monda V. The Beneficial Effects of Physical Activity in Lung Cancer Prevention and/or Treatment. Life 2022;12:782. [DOI: 10.3390/life12060782] [Reference Citation Analysis]
3 Wang Y, Wan Y, Qian Y, Khalaf OI. Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis. Computational and Mathematical Methods in Medicine 2021;2021:1-8. [DOI: 10.1155/2021/1068090] [Reference Citation Analysis]
4 Lang D, Ritzberger L, Rambousek V, Horner A, Wass R, Akbari K, Kaiser B, Kronbichler J, Lamprecht B, Gabriel M. First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes. Cancers (Basel) 2021;13:6096. [PMID: 34885206 DOI: 10.3390/cancers13236096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Joosten PJM, Dickhoff C, van der Noort V, Smeekens M, Numan RC, Klomp HM, van Diessen JNA, Belderbos JSA, Smit EF, Monkhorst K, Oosterhuis JWA, van den Heuvel MM, Dahele M, Hartemink KJ. Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer-results from a retrospective analysis. Interact Cardiovasc Thorac Surg 2021:ivab291. [PMID: 34734237 DOI: 10.1093/icvts/ivab291] [Reference Citation Analysis]
6 Reginelli A, Nardone V, Giacobbe G, Belfiore MP, Grassi R, Schettino F, Del Canto M, Grassi R, Cappabianca S. Radiomics as a New Frontier of Imaging for Cancer Prognosis: A Narrative Review. Diagnostics (Basel) 2021;11:1796. [PMID: 34679494 DOI: 10.3390/diagnostics11101796] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Spinnato P. The Importance of Accurate Tumor Measurements and Staging in Oncologic Imaging: Impact on Patients' Health. Acad Radiol 2021;28:767-8. [PMID: 33468419 DOI: 10.1016/j.acra.2021.01.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Yan M, Wang W. A radiomics model of predicting tumor volume change of patients with stage III non-small cell lung cancer after radiotherapy. Sci Prog 2021;104:36850421997295. [PMID: 33687294 DOI: 10.1177/0036850421997295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]